Published: 2018-10-18 03:08:37
SUMMARY
bioSyntagma is a precision medicine company that provides
deep data on the uniqueness of each person’s cancer to transform how their
cancer is treated.
bioSyntagma serves the needs of clinicians, academic
researchers, and drug developers to advance the implementation of precision
medicine.
The company has developed a
device that enables researchers and drug developers to physically map cancer
tissues for biological markers that predict the response to treatments and
outcomes.
Categories:
Innovations
Sign in or Create an account to comment!
